Tom Fleming

President & CEO

Tom Fleming comes to 4Tech with over 21 years of experience at Boston Scientific Corporation in numerous roles of increasing responsibility including Vice President (VP) and General Manager (GM) for Transcather Aortic Valves, Program Management, Interventional Cardiology, Cardiac Rhythm Management and Peripheral Interventions. He also held leadership roles in Imaging, Embolic Protection, Quality, and Marketing. In his most recent role as Vice President and General Manager for the Transcatheter Aortic Valve (TAVR), 2012 – 2017, he was responsible for leading Boston Scientific into the $3B global market for minimally invasive Transcather Aortic Valves.  With the Clinical Investigators and Boston Scientific team, he successfully drove the execution of the first comparative head to head randomized US IDE trial, which demonstrated superiority at one year.

Our Leadership